{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:40:03Z","timestamp":1762864803783},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1983,3,1]],"date-time":"1983-03-01T00:00:00Z","timestamp":415324800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1983,3,1]],"date-time":"1983-03-01T00:00:00Z","timestamp":415324800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[1983,3]]},"DOI":"10.1007\/bf00180194","type":"journal-article","created":{"date-parts":[[2004,8,22]],"date-time":"2004-08-22T10:50:22Z","timestamp":1093171822000},"page":"71-84","source":"Crossref","is-referenced-by-count":32,"title":["Diaziquone (AZQ)"],"prefix":"10.1007","volume":"1","author":[{"given":"John F.","family":"Bender","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio J.","family":"Grillo-Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Juan G.","family":"Posada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF00180194_CR1","first-page":"1","volume":"4","author":"JS Driscoll","year":"1974","unstructured":"Driscoll JS, Hazard GF Jr, Wood HB Jr, Goldin A: Structure-antitumor activity relationships among quinone derivatives. Cancer Chemother Rep 4(Part 2):1\u2013363, 1974","journal-title":"Cancer Chemother Rep"},{"key":"BF00180194_CR2","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1139\/v75-409","volume":"53","author":"MH Akhtar","year":"1975","unstructured":"Akhtar MH, Begleiter A, Johnson D, Lown JW, McLaughlin L, Kim SK: Studies related to antitumor antibiotics. Part IV. Correlation of covalent crosslinking of DNA by bifunctional aziridinoquinones with their antineoplastic activity. Can J Chem 53:2891\u20132905, 1975","journal-title":"Can J Chem"},{"key":"BF00180194_CR3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1146\/annurev.pa.02.040162.000545","volume":"2","author":"DP Rall","year":"1962","unstructured":"Rall DP, Zubrod CG: Mechanisms of drug absorption and excretion. Passage of drugs in and out of the central nervous system. Ann Rev Pharmacol 2:109\u2013128, 1962","journal-title":"Ann Rev Pharmacol"},{"key":"BF00180194_CR4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1021\/jm00224a022","volume":"19","author":"AH Khan","year":"1976","unstructured":"Khan AH, Driscoll JS: Potential central nervous system antitumor agents. Aziridinylbenzoquinones, 1. J Med Chem 19:313\u2013317, 1976","journal-title":"J Med Chem"},{"key":"BF00180194_CR5","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1021\/jm00233a010","volume":"19","author":"F Chou","year":"1976","unstructured":"Chou F, Khan AH, Driscoll JS: Potential central nervous system antitumor agents. Aziridinylbenzoquinones, 2. J Med Chem 19:1302\u20131308, 1976","journal-title":"J Med Chem"},{"key":"BF00180194_CR6","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/jps.2600680217","volume":"68","author":"JS Driscoll","year":"1979","unstructured":"Driscoll JS, Dudeck L, Congleton G, Geran RI: Potential CNS antitumor agents VI: Aziridinylbenzoquinones III. J Pharm Sci 68:185\u2013188, 1979","journal-title":"J Pharm Sci"},{"key":"BF00180194_CR7","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/jps.2600700211","volume":"70","author":"GK Poochikian","year":"1981","unstructured":"Poochikian GK, Cradock JC: 2,5-Diaziridinyl-3,6-bis (carboethoxyamino)-1,4-benzoquinone I: Kinetics in aqueous solutions by high-performance liquid chromatography. J Pharm Sci 70:159\u2013162, 1981","journal-title":"J Pharm Sci"},{"key":"BF00180194_CR8","first-page":"339","volume":"66","author":"PL Gutierrez","year":"1982","unstructured":"Gutierrez PL, Friedman RD, Bachur NR: Biochemical activation of AZQ [3,6-diaziridinyl-2,5-bis(carboethoxya-mino)-1,4-benzoquinone] to its free radical species. Cancer Treat Rep 66:339\u2013342, 1982","journal-title":"Cancer Treat Rep"},{"key":"BF00180194_CR9","unstructured":"Data on file at NCI: Clinical Brochure"},{"key":"BF00180194_CR10","unstructured":"Preclinical toxicologic evaluation of aziridinylbenzoquinone (NSC-182986) in dogs, monkeys, and mice. December 15, 1978. Midwest Research Institute, Kansas City, MO 64110"},{"key":"BF00180194_CR11","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000137490","volume":"22","author":"PE Gormley","year":"1981","unstructured":"Gormley PE, Wood JH, Poplack DG: Ability of a new anti-tumor agent, AZQ, to penetrate into cerebrospinal fluid. Pharmacology 22:196\u2013198, 1981","journal-title":"Pharmacology"},{"key":"BF00180194_CR12","first-page":"180","volume":"22","author":"K Lu","year":"1981","unstructured":"Lu K, Savaraj N, Yap BS, Bedikian AY, Feun LG, Loo TL: Clinical pharmacology of 2,5-diaziridinyl-3,6-bis-carboethoxyamino-1,4-benzoquinone, (AZQ, NSC-182986). Proc Am Assoc Cancer Res 22:180, 1981 (Abstract)","journal-title":"Proc Am Assoc Cancer Res"},{"key":"BF00180194_CR13","first-page":"351","volume":"22","author":"N Savaraj","year":"1981","unstructured":"Savaraj N, Lu K, Stewart D, Leavens M, Bedekian A, Feun L, Loo TL; Tissue distribution and intracerebral tumor penetration of 2,5-diaziridinyl-3,6-biscarboethoxyamino-1,4-benzoquinone (AZQ, NSC-182986) in man. Proc Am Assoc Cancer Res 22:351, 1981 (Abstract)","journal-title":"Proc Am Assoc Cancer Res"},{"key":"BF00180194_CR14","first-page":"1321","volume":"66","author":"JP Griffin","year":"1982","unstructured":"Griffin JP, Newman RA, McCormack JJ, Krakoff IH: Clinical and clinical pharmacologic studies of aziridinylben-zoquinone. Cancer Treat Rep 66:1321\u20131325, 1982","journal-title":"Cancer Treat Rep"},{"key":"BF00180194_CR15","first-page":"1582","volume":"42","author":"RL Schilsky","year":"1982","unstructured":"Schilsky RL, Kelley JA, Ihde DC, Howser DM, Cordes RS, Young RC: Phase I trial and pharmacokinetics of aziridinylbenzoquinone (NSC 182986) in humans. Cancer Res 42:1582\u20131586, 1982","journal-title":"Cancer Res"},{"key":"BF00180194_CR16","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/00000421-198208000-00010","volume":"5","author":"DA VanEcho","year":"1982","unstructured":"VanEcho DA, Schulman P, Budman DR, Ferrari A, Wiernik PH: A phase I trial of aziridinylbenzoquinone (NSC 182986) in patients with previously treated leukemia. Am J Clin Oncol 5:405\u2013410, 1982","journal-title":"Am J Clin Oncol"},{"key":"BF00180194_CR17","first-page":"459","volume":"4","author":"AY Bedikian","year":"1981","unstructured":"Bedikian AY, Bodey GP, Burgess MA, Freireich EJ: Phase I study of aziridinylbenzoquinone (NSC 182986). Cancer Clin Trials 4:459\u2013463, 1981","journal-title":"Cancer Clin Trials"},{"key":"BF00180194_CR18","first-page":"120","volume":"22","author":"C Tan","year":"1982","unstructured":"Tan C, Hancock, Miller L, Capparas B, Leyland-Jones B: Phase I study of aziridinylbenzoquinone in children with cancer. Proc Am Assoc Cancer Res 22:120, 1982 (Abstract)","journal-title":"Proc Am Assoc Cancer Res"},{"key":"BF00180194_CR19","first-page":"24","volume":"1","author":"MY Whitacre","year":"1982","unstructured":"Whitacre MY, VanEcho DA, Budman DR, Shulman P, Aisner J, Wiernik PH: A phase I trial of five-day continuous infusion aziridinylbenzoquinone (AZQ, NSC 182986). Proc Am Soc Clin Oncol 1:24, 1982 (Abstract)","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF00180194_CR20","first-page":"189","volume":"22","author":"L Baker","year":"1981","unstructured":"Baker L, Samson M, Leichman C, Young J: Phase I evaluation of aziridinylbenzoquinone (NSC 182986) in a weekly IV schedule. Proc Am Assoc Cancer Res 22:189, 1981 (Abstract)","journal-title":"Proc Am Assoc Cancer Res"},{"key":"BF00180194_CR21","first-page":"389","volume":"22","author":"SA Taylor","year":"1981","unstructured":"Taylor SA, Belt RJ, Haas C, Hoogstraten B, Stephens RL: Phase I trial of carbamic acid (AZQ, NSC 182986). Proc Am Assoc Cancer Res 22:389, 1981 (Abstract)","journal-title":"Proc Am Assoc Cancer Res"},{"key":"BF00180194_CR22","first-page":"452","volume":"22","author":"AY Bedikian","year":"1981","unstructured":"Bedikian AY, Stroehlein JR, Karlin DA, Bennetts RW, Bodey GP: Clinical evaluation of aziridinylbenzoquinone (AZQ, NSC 182986) in patients with advanced colorectal cancer. Proc Am Assoc Res 22:452, 1981 (Abstract)","journal-title":"Proc Am Assoc Res"},{"key":"BF00180194_CR23","first-page":"13","volume":"1","author":"GA Curt","year":"1982","unstructured":"Curt GA, Schilsky R, Kelly J, Kufta C, Smith B, Thomas C, Young RC: Phase II study of aziridinylbenzoquinone (AZQ) in high grade gliomas. Proc Am Soc Clin Oncol 1:13, 1982 (Abstract)","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF00180194_CR24","first-page":"24","volume":"1","author":"RS Aroney","year":"1982","unstructured":"Aroney RS, Kaplan RS, Salcman M, Montgomery E, Wiernik PH: A phase II trial of AZQ (NSC 182986) in patients with recurrent primary or metastatic brain tumors. Proc Am Soc Clin Oncol 1:24, 1982 (Abstract)","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF00180194_CR25","first-page":"117","volume":"1","author":"WC Nichols","year":"1982","unstructured":"Nichols WC, Kvols LK, Richardson RL, Benson RC: A phase II study of aziridinylbenzoquinone (AZQ) in advanced genitourinary (GU) cancer. Proc Am Soc Clin Oncol 1:117, 1982 (Abstract)","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF00180194_CR26","first-page":"134","volume":"1","author":"RS Walters","year":"1982","unstructured":"Walters RS, Keating MJ, Bodey GP, McCredie RS, Freireich EJ: Phase I \u2013 II study of aziridinylbenzoquinone in acute leukemia. Proc Am Soc Clin Oncol 1:134, 1982 (Abstract)","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF00180194_CR27","first-page":"148","volume":"1","author":"J Aisner","year":"1982","unstructured":"Aisner J, Fuks JZ, VanEcho DA, Budman D, Carney D, Levitt M, Klein M, Wiernik PH: Phase II study of aziridinylbenzoquinone (AZQ) in patients with refractory small cell carcinoma of the lung. Proc Am Soc Clin Oncol 1:148, 1982 (Abstract)","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF00180194_CR28","first-page":"155","volume":"1","author":"RW Carey","year":"1982","unstructured":"Carey RW, Comis RL: Phase II evaluation of aziridinyl-benzoquinone (AZQ) in the primary treatment of locally advanced or extensive nonsmall cell lung cancer. Proc Am Soc Clin Oncol 1:155, 1982 (Abstract)","journal-title":"Proc Am Soc Clin Oncol"},{"key":"BF00180194_CR29","first-page":"151","volume":"1","author":"LG Feun","year":"1982","unstructured":"Feun LG, Savaraj N, Bedikian AY, Leavens M, Burgess MA, Lu K, Smith RG, Benjamin RS, Bodey GP: Phase II study of 2,5-diaziridinyl, 3,6-bis(carboethoxyamino)-1,4-benzoquinone (AZQ, NSC 182986) in recurrent malignant gliomas. Proc Am Assoc Cancer Res 1:151, 1982 (Abstract)","journal-title":"Proc Am Assoc Cancer Res"},{"key":"BF00180194_CR30","unstructured":"Eagan R: Phase II study of AZQ in brain tumors. Cancer Clin Trials, 1982 (In press)"},{"key":"BF00180194_CR31","unstructured":"Yap HY: Phase II study of AZQ in advanced breast cancer. Cancer Clin Trials, 1982 (In press)"},{"key":"BF00180194_CR32","unstructured":"Budman RD, Forestiere A, Perloff M, Perry M, Aisner J, Weinberg V, Woods W: CALGB phase II trials: AZQ in advanced breast cancer. Cancer Treat Rep, 1982 (In press)"},{"key":"BF00180194_CR33","unstructured":"Yap BS: Phase II study of AZQ in malignant melanoma. Cancer Clin Trials, 1982 (In press)"},{"key":"BF00180194_CR34","unstructured":"Creagan E: Personal communication in minutes of the December 15\u201316 1981 New Drug Liaison Meeting. National Cancer Institute. Bethesda, Maryland"},{"key":"BF00180194_CR35","unstructured":"Samson M: Personal communication in minutes of the December 15\u201316 1981 New Drug Liaison Meeting. National Cancer Institute. Bethesda, Maryland"},{"key":"BF00180194_CR36","unstructured":"Bodey G: Personal communication in minutes of the New Drug Liaison Meeting. Bethesda National Cancer Institute. March 1982"},{"key":"BF00180194_CR37","unstructured":"Yap BS: Personal communication in minutes of the New Drug Liaison Meeting. Bethesda National Cancer Institute. December 1981"},{"key":"BF00180194_CR38","unstructured":"Eagan R: Personal communication in minutes of the New Drug Liaison Meeting. Bethesda National Cancer Institute December 1981"},{"key":"BF00180194_CR39","unstructured":"Ettinger L: A phase I study of aziridinylbenzoquinone (AZQ) in children with acute leukemia. Accepted for presentation by American Society of Hematology, December, 1982"},{"key":"BF00180194_CR40","unstructured":"Rubin J: Personal communication in minutes of New Drug Liaison Meeting. Bethesda National Cancer Institute. June 1981"},{"key":"BF00180194_CR41","unstructured":"Leichman L: Personal communication"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00180194.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF00180194\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00180194","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00180194.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T18:28:34Z","timestamp":1678559314000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF00180194"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1983,3]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1983,3]]}},"alternative-id":["BF00180194"],"URL":"https:\/\/doi.org\/10.1007\/bf00180194","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"value":"0167-6997","type":"print"},{"value":"1573-0646","type":"electronic"}],"subject":[],"published":{"date-parts":[[1983,3]]}}}